Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TLC VITA is a comprehensive nutritional supplement developed by Remed Pharmaceuticals, Inc. and manufactured by Lloyd Laboratories, Inc. in the Philippines. It is formulated as a combination of essential vitamins and minerals, further enriched with taurine, lysine, and Chlorella Growth Factor (CGF). The supplement is designed to address micronutrient deficiencies and provide general nutritional support, particularly to aid in the growth and development of pediatric populations. It is available in various oral forms, including capsules, syrup, and drops. The mechanism of action involves the replenishment of essential vitamins and minerals required for various metabolic processes, while the additional components like lysine and taurine support protein synthesis and neurological health, and CGF is intended to promote cellular repair and growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TLC VITA.